glp-1 receptor agonists adverse effects Gastrointestinal effect and of agonist Safety and Tolerability of Glucagon-Like
Description
Patients with newly diagnosed thyroid or neck masses should be asked about the use of these medications
Glucagon-like peptide-1 receptor agonists and gastrointestinal adverse events: a systematic review and meta-analysis
Figure was created by the author
However, most of these studies used standard doses approved for diabetes or obesity, and dedicated trials examining low-dose GLP-1 specifically for inflammatory conditions are lacking
43 established that an AMPK-dependent pathway promotes inhibition of lipogenesis by GLP-1 in rats fed a high-fat diet
